Trade-off between the Use of Nonterminals, Codings and Homomorphisms in Defining Languages for Some Classes of Rewriting Systems

A. Ehrenfeucht,G. Rozenberg

DOI: https://doi.org/10.1007/3-540-06841-4_83

1974-07-29

Abstract:

What problem does this paper attempt to address?

A Multiple Deep Trench Isolation Structure with Voltage Divider Biasing

B. Desoete,A. De Smet,P. Moens

DOI: https://doi.org/10.1109/ISPSD.2007.4294970

2007-05-27

Abstract:We present an isolation structure with multiple rings of deep trenches, which has proven to have an excellent latchup suppression capability. The regions between the trenches are contacted, allowing to increase the blocking voltage of the structure by applying an appropriate bias arrangement. A simple model to predict the optimal bias voltages is derived, and compared to TCAD simulations and measurements.
The Role of Autophagy in Inflammatory Bowel Disease

Bo-Zong Shao,Yi Yao,Jun-Shan Zhai,Jian-Hua Zhu,Jin-Ping Li,Kai Wu

DOI: https://doi.org/10.3389/fphys.2021.621132

IF: 4

2021-02-03

Frontiers in Physiology

Abstract:Inflammatory bowel disease (IBD) is an idiopathic intestinal inflammatory disease, including ulcerative colitis (UC) and Crohn’s disease (CD). The abnormality of inflammatory and immune responses in the intestine contributes to the pathogenesis and progression of IBD. Autophagy is a vital catabolic process in cells. Recent studies report that autophagy is highly involved in various kinds of diseases, especially inflammation-related diseases, such as IBD. In this review, the biological characteristics of autophagy and its role in IBD will be described and discussed based on recent literature. In addition, several therapies for IBD through modulating the inflammasome and intestinal microbiota taking advantage of autophagy regulation will be introduced. We aim to bring new insight in the exploration of mechanisms for IBD and development of novel therapeutic strategies against IBD.

physiology
Autophagy and proinflammatory cytokines: Interactions and clinical implications.

Yun Ge,Man Huang,Yong-Ming Yao

DOI: https://doi.org/10.1016/j.cytogfr.2018.07.001

IF: 17.66

2018-01-01

Cytokine & Growth Factor Reviews

Abstract:•Autophagy is induced by interferon (IFN)-γ, interleukin (IL)-1, tumor necrosis factor (TNF)-α, IL-17, and IL-6, whereas the process is blocked by IL-13, IL-33, IL-10, and IL-4.•Autophagy facilitates the production of IFN-γ, TNF-α, IL-1β and inhibits the secretion of TNF-α, IL-17, IL-1β, IL-α.•Autophagy is a promising target for developing novel therapeutic strategies against inflammatory and infectious diseases.•TNF-α, IL-1β, and IFN-γ promote autophagy and prevent pathogen invasion; Moreover, IFN-γ can promote the generation of immunity in diseases involving immunosuppression.•On the other hand, TNF-α, IL-1β, or IL-17 can trigger excessive autophagy, which contributes to the pathophysiology of several diseases.
Roles of Autophagy-Related Genes in the Pathogenesis of Inflammatory Bowel Disease

Sup Kim,Hyuk Soo Eun,Eun-Kyeong Jo

DOI: https://doi.org/10.3390/cells8010077

IF: 6

2019-01-21

Cells

Abstract:Autophagy is an intracellular catabolic process that is essential for a variety of cellular responses. Due to its role in the maintenance of biological homeostasis in conditions of stress, dysregulation or disruption of autophagy may be linked to human diseases such as inflammatory bowel disease (IBD). IBD is a complicated inflammatory colitis disorder; Crohn's disease and ulcerative colitis are the principal types. Genetic studies have shown the clinical relevance of several autophagy-related genes (ATGs) in the pathogenesis of IBD. Additionally, recent studies using conditional knockout mice have led to a comprehensive understanding of ATGs that affect intestinal inflammation, Paneth cell abnormality and enteric pathogenic infection during colitis. In this review, we discuss the various ATGs involved in macroautophagy and selective autophagy, including ATG16L1, IRGM, LRRK2, ATG7, p62, optineurin and TFEB in the maintenance of intestinal homeostasis. Although advances have been made regarding the involvement of ATGs in maintaining intestinal homeostasis, determining the precise contribution of autophagy has remained elusive. Recent efforts based on direct targeting of ATGs and autophagy will further facilitate the development of new therapeutic opportunities for IBD.
Inflammatory Bowel Disease: Dysfunction of Autophagy?

Michael Scharl,Gerhard Rogler

DOI: https://doi.org/10.1159/000342588

2012-01-01

Digestive Diseases

Abstract:Recent genome-wide association studies identified single nucleotide polymorphisms within gene loci, encoding autophagy genes, e.g. the autophagy-related 16-like 1 (ATG16L1) and the immunity-related GTPase family M (IRGM), as an important risk factor for the onset of chronic inflammatory diseases such as Crohn's disease (CD) or rheumatoid arthritis. CD is characterized by a breakdown of the intestinal epithelial barrier function leading to an overwhelming and uncontrolled immune response to bacterial antigens. Autophagy, and therefore ATG16L1 and IRGM, are critically involved in the innate immune response to invading pathogens. Dysfunction of these molecules results in the increased survival of intracellular bacteria, defective antigen presentation and proinflammatory cytokine secretion. Interestingly, autophagy can also be regulated by other CD susceptibility genes, such as nucleotide oligomerization domain 2 or protein tyrosine phosphatase nonreceptor type 2, and the presence of the CD-associated variations within these genes results in comparable effects. ATG16L1 also plays a crucial role in maintaining Paneth cell function and morphology, while IRGM seems to be associated with mitochondrial function and apoptosis. Dysfunction of these molecules, i.e. of autophagy in vivo, is clearly associated with the increased bacterial infection and the onset of colitis. Interestingly, the phenotype of aberrant Paneth cells and dextran sodium sulphate-induced colitis in ATG16L1 hypomorphic mice closely resembles human CD. Taken together, the available data strongly suggest an important role for autophagy in maintaining intestinal homeostasis, and dysfunction of autophagy seems to be a major risk factor for the onset of chronic intestinal inflammation.

gastroenterology & hepatology
Deciphering the role of autophagy in the immunopathogenesis of inflammatory bowel disease

Yue Li,Helen Ka Wai Law

DOI: https://doi.org/10.3389/fphar.2022.1070184

IF: 5.6

2022-11-14

Frontiers in Pharmacology

Abstract:Inflammatory bowel disease (IBD) is a typical immune-mediated chronic inflammatory disorder. Following the industrialization and changes in lifestyle, the incidence of IBD in the world is rising, which makes health concerns and heavy burdens all over the world. However, the pathogenesis of IBD remains unclear, and the current understanding of the pathogenesis involves dysregulation of mucosal immunity, gut microbiome dysbiosis, and gut barrier defect based on genetic susceptibility and environmental triggers. In recent years, autophagy has emerged as a key mechanism in IBD development and progression because Genome-Wide Association Study revealed the complex interactions of autophagy in IBD, especially immunopathogenesis. Besides, autophagy markers are also suggested to be potential biomarkers and target treatment in IBD. This review summarizes the autophagy-related genes regulating immune response in IBD. Furthermore, we explore the evolving evidence that autophagy interacts with intestinal epithelial and immune cells to contribute to the inflammatory changes in IBD. Finally, we discuss how novel discovery could further advance our understanding of the role of autophagy and inform novel therapeutic strategies in IBD.

pharmacology & pharmacy
The emerging roles of autophagy in intestinal epithelial cells and its links to inflammatory bowel disease

Sharon Tran,Juliani Juliani,W Douglas Fairlie,Erinna F Lee

DOI: https://doi.org/10.1042/BST20221300

2023-04-26

Abstract:Landmark genome-wide association studies (GWAS) identified that mutations in autophagy genes correlated with inflammatory bowel disease (IBD), a heterogenous disease characterised by prolonged inflammation of the gastrointestinal tract, that can reduce a person's quality of life. Autophagy, the delivery of intracellular components to the lysosome for degradation, is a critical cellular housekeeping process that removes damaged proteins and turns over organelles, recycling their amino acids and other constituents to supply cells with energy and necessary building blocks. This occurs under both basal and challenging conditions such as nutrient deprivation. An understanding of the relationship between autophagy, intestinal health and IBD aetiology has improved over time, with autophagy having a verified role in the intestinal epithelium and immune cells. Here, we discuss research that has led to an understanding that autophagy genes, including ATG16L, ATG5, ATG7, IRGM, and Class III PI3K complex members, contribute to innate immune defence in intestinal epithelial cells (IECs) via selective autophagy of bacteria (xenophagy), how autophagy contributes to the regulation of the intestinal barrier via cell junctional proteins, and the critical role of autophagy genes in intestinal epithelial secretory subpopulations, namely Paneth and goblet cells. We also discuss how intestinal stem cells can utilise autophagy. Importantly, mouse studies have provided evidence that autophagy deregulation has serious physiological consequences including IEC death and intestinal inflammation. Thus, autophagy is now established as a key regulator of intestinal homeostasis. Further research into how its cytoprotective mechanisms can prevent intestinal inflammation may provide insights into the effective management of IBD.
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD

Anaïs Larabi,Nicolas Barnich,Hang Thi Thu Nguyen

DOI: https://doi.org/10.1080/15548627.2019.1635384

IF: 13.391

2019-07-09

Autophagy

Abstract:One of the most significant challenges of inflammatory bowel disease (IBD) research is to understand how alterations in the symbiotic relationship between the genetic composition of the host and the intestinal microbiota, under impact of specific environmental factors, lead to chronic intestinal inflammation. Genome-wide association studies, followed by functional studies, have identified a role for numerous autophagy genes in IBD, especially in Crohn disease. Studies using in vitro and in vivo models, in addition to human clinical studies have revealed that autophagy is pivotal for intestinal homeostasis maintenance, gut ecology regulation, appropriate intestinal immune responses and anti-microbial protection. This review describes the latest researches on the mechanisms by which dysfunctional autophagy leads to disrupted intestinal epithelial function, gut dysbiosis, defect in anti-microbial peptide secretion by Paneth cells, endoplasmic reticulum stress response and aberrant immune responses to pathogenic bacteria. A better understanding of the role of autophagy in IBD pathogenesis may provide better sub-classification of IBD phenotypes and novel approaches for disease management.Abbreviations: AIEC: adherent-invasive Escherichia coli; AMPK: AMP-activated protein kinase; ATF6: activating transcription factor 6; ATG: autophagy related; Atg16l1[ΔIEC] mice: mice with Atg16l1 depletion specifically in intestinal epithelial cells; Atg16l1[HM] mice: mice hypomorphic for Atg16l1 expression; BCL2: B cell leukemia/lymphoma 2; BECN1: beclin 1, autophagy related; CALCOCO2: calcium binding and coiled-coil domain 2; CASP: caspase; CD: Crohn disease; CGAS: cyclic GMP-AMP synthase; CHUK/IKKA: conserved helix-loop-helix ubiquitous kinase; CLDN2: claudin 2; DAPK1: death associated protein kinase 1; DCs: dendritic cells; DSS: dextran sulfate sodium; EIF2A: eukaryotic translation initiation factor 2A; EIF2AK: eukaryotic translation initiation factor 2 alpha kinase; ER: endoplasmic reticulum; ERBIN: Erbb2 interacting protein; ERN1/IRE1A: ER to nucleus signaling 1; FNBP1L: formin binding protein 1-like; FOXP3: forkhead box P3; GPR65: G-protein coupled receptor 65; GSK3B: glycogen synthase kinase 3 beta; IBD: inflammatory bowel disease; IECs: intestinal epithelial cells; IFN: interferon; IL: interleukin; IL10R: interleukin 10 receptor; IRGM: immunity related GTPase M; ISC: intestinal stem cell; LAMP1: lysosomal-associated membrane protein 1; LAP: LC3-associated phagocytosis; MAP1LC3B: microtubule-associated protein 1 light chain 3 beta; LPS: lipopolysaccharide; LRRK2: leucine-rich repeat kinase 2; MAPK: mitogen-activated protein kinase; MHC: major histocompatibility complex; MIF: macrophage migration inhibitory factor; MIR/miRNA: microRNA; MTMR3: myotubularin related protein 3; MTOR: mechanistic target of rapamycin kinase; MYD88: myeloid differentiation primary response gene 88; NLRP3: NLR family, pyrin domain containing 3; NOD2: nucleotide-binding oligomerization domain containing 2; NPC: Niemann-Pick disease type C; NPC1: NPC intracellular cholesterol transporter 1; OMVs: outer membrane vesicles; OPTN: optineurin; PI3K: phosphoinositide 3-kinase; PRR: pattern-recognition receptor; PTPN2: protein tyrosine phosphatase, non-receptor type 2; PTPN22: protein tyrosine phosphatase, non-receptor type 22 (lymphoid); PYCARD/ASC: PYD and CARD domain containing; RAB2A: RAB2A, member RAS oncogene family; RELA: v-rel reticuloendotheliosis viral oncogene homolog A (avian); RIPK2: receptor (TNFRSF)-interacting serine-threonine kinase 2; ROS: reactive oxygen species; SNPs: single nucleotide polymorphisms; SQSTM1: sequestosome 1; TAX1BP1: Tax1 binding protein 1; Th: T helper 1; TIRAP/TRIF: toll-interleukin 1 receptor (TIR) domain-containing adaptor protein; TLR: toll-like receptor; TMEM173/STING: transmembrane protein 173; TMEM59: transmembrane protein 59; TNF/TNFA: tumor necrosis factor; Treg: regulatory T; TREM1: triggering receptor expressed on myeloid cells 1; UC: ulcerative colitis; ULK1: unc-51 like autophagy activating kinase 1; WT: wild-type; XBP1: X-box binding protein 1; XIAP: X-linked inhibitor of apoptosis.
[Research updates: the mechanism of autophagy in inflammatory bowel disease]

Shengnan Huang,Fangfang Li,Dan Jin

Abstract:Inflammatory bowel disease (IBD) is a non-specific intestinal inflammatory disease with slow onset, varying severity and recurrence. Even though the causes of IBD are still unknown, studies have indicated that the pathogenesis of IBD is associated with multiple factors, including environment, genetics, infection and immunity. Autophagy is involved in regulating the immune response of IBD through a variety of ways such as pathogen removal, immune function, regulation of inflammatory signals, or inhibition of inflammasomes. Recent studies suggested that autophagy-related genes including ATG16L1, IRGM, and NOD2 are highly susceptible genes related to IBD, and gene deletion and mutation affect the occurrence and development of IBD. Hereby, we review the mechanism of autophagy and its related genes regulating the cytokines secretion and adjusting the immune response in IBD.
How autophagy, a potential therapeutic target, regulates intestinal inflammation

Shuang-Lan Chen,Chun-Meng Li,Wei Li,Qing-Song Liu,Shuang-Yuan Hu,Mao-Yuan Zhao,Dong-Sen Hu,Yan-Wei Hao,Jin-Hao Zeng,Yi Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1087677

IF: 7.3

2023-04-25

Frontiers in Immunology

Abstract:Inflammatory bowel disease (IBD) is a group of disorders that cause chronic inflammation in the intestines, with the primary types including ulcerative colitis and Crohn's disease. The link between autophagy, a catabolic mechanism in which cells clear protein aggregates and damaged organelles, and intestinal health has been widely studied. Experimental animal studies and human clinical studies have revealed that autophagy is pivotal for intestinal homeostasis maintenance, gut ecology regulation and other aspects. However, few articles have summarized and discussed the pathways by which autophagy improves or exacerbates IBD. Here, we review how autophagy alleviates IBD through the specific genes (e.g., ATG16L1 , IRGM , NOD2 and LRRK2 ), crosstalk of multiple phenotypes with autophagy (e.g., Interaction of autophagy with endoplasmic reticulum stress, intestinal antimicrobial defense and apoptosis) and autophagy-associated signaling pathways. Moreover, we briefly discuss the role of autophagy in colorectal cancer and current status of autophagy-based drug research for IBD. It should be emphasized that autophagy has cell-specific and environment-specific effects on the gut. One of the problems of IBD research is to understand how autophagy plays a role in intestinal tract under specific environmental factors. A better understanding of the mechanism of autophagy in the occurrence and progression of IBD will provide references for the development of therapeutic drugs and disease management for IBD in the future.

immunology
Autophagy and Apoptosis in Inflammatory Bowel Disease

Elias Kouroumalis,Ioannis Tsomidis,Argyro Voumvouraki

DOI: https://doi.org/10.3390/gastroent14040042

2023-11-22

Gastroenterology Insights

Abstract:The pathogenesis of inflammatory bowel disease (IBD) implicates several interconnecting factors. Immunity and external factors interact, and most aspects are still under investigation. Autophagy and apoptosis are two critical pathways that decide the fate of the individual cells of the intestinal mucosa. Experimental and clinical data indicate that the two are closely interconnected and usually mutually exclusive. However, despite the abundant information on their role, very limited translation into therapeutic application has been seen during recent years. In this review, research on these two pathways is presented. After a general overview of autophagy and apoptosis, their association with IBD, including the important mitophagy and ferroptosis, is discussed. The influence of autophagy- and apoptosis-related genes is also discussed. Finally, the interplay of autophagy and apoptosis in IBD is presented and the implications for treatment applications are examined. It is shown that dysregulated autophagy leads to increased apoptosis of enterocytes and impairs the tight junction proteins of the protective intestinal barrier. Dysregulated autophagy also induces the downregulation of lysozyme and the other antimicrobial proteins’ production. Mucus production by the goblet cells is also reduced due to defective autophagy and increased apoptosis.
Interplay of autophagy and innate immunity in Crohn's disease: a key immunobiologic feature

Györgyi Műzes,Zsolt Tulassay,Ferenc Sipos

DOI: https://doi.org/10.3748/wjg.v19.i28.4447

2013-07-28

Abstract:Crohn's disease representing a clinical phenotype of inflammatory bowel disease is a polygenic immune disorder with complex multifactor etiology. Recent genome-wide association studies of susceptibility loci have highlighted on the importance of the autophagy pathway, which previously had not been implicated in disease pathology. Autophagy represents an evolutionarily highly conserved multi-step process of cellular self-digestion due to sequestration of excessive, damaged, or aged proteins and intracellular organelles in double-membranous vesicles of autophagosomes, terminally self-digested in lysosomes. Autophagy is deeply involved in regulation of cell development and differentiation, survival and senescence, and it also fundamentally affects the inflammatory pathways, as well as the innate and adaptive arms of immune responses. Autophagy is mainly activated due to sensors of the innate immunity, i.e., by pattern recognition receptor signaling. The interplay of genes regulating immune functions is strongly influenced by the environment, especially gut resident microbiota. The basic challenge for intestinal immune recognition is the requirement of a simultaneous delicate balance between tolerance and responsiveness towards microbes. On the basis of autophagy-related risk genetic polymorphisms (ATG16L1, IRGM, NOD2, XBP1) impaired sensing and handling of intracellular bacteria by innate immunity, closely interrelated with the autophagic and unfolded protein pathways seem to be the most relevant immunobiologic events. Autophagy is now widely considered as a key regulator mechanism with the capacity to integrate several aspects of Crohn's disease pathogenesis. In this review, recent advances in the exciting crosstalk of susceptibility coding variants-related autophagy and innate immunity are discussed.
Autophagy in Crohn's Disease: Converging on Dysfunctional Innate Immunity

Kibrom M Alula,Arianne L Theiss

DOI: https://doi.org/10.3390/cells12131779

IF: 6

2023-07-04

Cells

Abstract:Crohn's disease (CD) is a chronic inflammatory bowel disease marked by relapsing, transmural intestinal inflammation driven by innate and adaptive immune responses. Autophagy is a multi-step process that plays a critical role in maintaining cellular homeostasis by degrading intracellular components, such as damaged organelles and invading bacteria. Dysregulation of autophagy in CD is revealed by the identification of several susceptibility genes, including ATG16L1, IRGM, NOD2, LRRK2, ULK1, ATG4, and TCF4, that are involved in autophagy. In this review, the role of altered autophagy in the mucosal innate immune response in the context of CD is discussed, with a specific focus on dendritic cells, macrophages, Paneth cells, and goblet cells. Selective autophagy, such as xenophagy, ERphagy, and mitophagy, that play crucial roles in maintaining intestinal homeostasis in these innate immune cells, are discussed. As our understanding of autophagy in CD pathogenesis evolves, the development of autophagy-targeted therapeutics may benefit subsets of patients harboring impaired autophagy.
Regulation of interferon signaling in response to gut microbes by autophagy

Patricia K Martin,Ken Cadwell

DOI: https://doi.org/10.1080/19490976.2019.1614395

IF: 12.2

Gut Microbes

Abstract:The cellular degradative pathway of autophagy prevents unrestrained inflammatory signaling by removing intracellular microbes, damaged organelles, and other factors that trigger immune reactions. Consistent with this function, a common variant of the autophagy gene ATG16L1 is associated with susceptibility to inflammatory bowel disease (IBD), a disorder characterized by a chronic immune reaction directed against the gut microbiota. We recently contributed to our understanding of the link between autophagy and inflammatory signaling in the intestine by demonstrating that autophagy proteins including ATG16L1 are necessary in the epithelium to prevent a spontaneous type I interferon response to the gut microbiota. Enhanced innate immunity that occurs upon autophagy inhibition is protective in mouse models of infection by an enteric bacterial pathogen and acute epithelial injury. Although avoiding excess immune reactions towards the microbiota is necessary to prevent IBD, these observations indicate that autophagy hampers productive immunity at the intestinal epithelial barrier in certain contexts. Here, we discuss how this counterintuitive consequence of autophagy inhibition can be reconciled with the established beneficial role of the pathway.
Targeting macrophage autophagy for inflammation resolution and tissue repair in inflammatory bowel disease

Er-jin Wang,Ming-Yue Wu,Zheng-yu Ren,Ying Zheng,Richard D Ye,Chris Soon Heng TAN,Yitao Wang,Jia-Hong Lu

DOI: https://doi.org/10.1093/burnst/tkad004

2023-01-01

Burns & Trauma

Abstract:Abstract Inflammatory bowel disease (IBD) is a chronic, non-specific, recurrent inflammatory disease, majorly affecting the gastrointestinal tract. Due to its unclear pathogenesis, the current therapeutic strategy for IBD is focused on symptoms alleviation. Autophagy is a lysosome-mediated catabolic process for maintaining cellular homeostasis. Genome-wide association studies and subsequent functional studies have highlighted the critical role of autophagy in IBD via a number of mechanisms, including modulating macrophage function. Macrophages are the gatekeepers of intestinal immune homeostasis, especially involved in regulating inflammation remission and tissue repair. Interestingly, many autophagic proteins and IBD-related genes have been revealed to regulate macrophage function, suggesting that macrophage autophagy is a potentially important process implicated in IBD regulation. Here, we have summarized current understanding of macrophage autophagy function in pathogen and apoptotic cell clearance, inflammation remission and tissue repair regulation in IBD, and discuss how this knowledge can be used as a strategy for IBD treatment.

dermatology,surgery,emergency medicine
Cutting World Hunger in Half

P. Sánchez,M. Swaminathan

DOI: https://doi.org/10.1126/SCIENCE.1109057

IF: 56.9

2005-01-21

Science

Abstract:To reach the Millennium Development Goal of halving hunger by 2015, the Millennium Project9s Task Force on Hunger recommends seven mutually reinforcing actions: political action; national policy reforms; increased agricultural productivity for food-insecure farmers; improved nutrition for the chronically hungry; productive safety nets for the acutely hungry; improved rural incomes and markets; and restored natural resources essential for food security. The Task Force concludes that "it can be done"-the Hunger MDG can be attained. In this Policy Forum, the task force chairmen explain why achieving that goal will require unprecedented levels of effort, but it is well within the reach of our technical and financial capabilities.
Thermodynamics of core hydrophobicity and packing in the hyperthermophile proteins Sac7d and Sso7d.

A. Clark,B. S. McCrary,S. Edmondson,J. Shriver

DOI: https://doi.org/10.1021/BI0358263

IF: 3.321

2004-02-18

Biochemistry

Abstract:The influence of core hydrophobicity and packing on the structure and stability of the hyperthermophile proteins Sac7d and Sso7d have been studied by calorimetry, circular dichroism, and NMR. Valine 30 is positioned in Sac7d to allow a cavity-filling Val --> Ile substitution which occurs naturally in the homologous more thermostable Sso7d. The cavity-filling mutation in Sac7d has been characterized and compared to the reciprocal Ile --> Val mutation in Sso7d. A detailed analysis of the stability of the proteins was obtained by globally fitting the variation of DSC parameters and circular dichroism intensities as a function of temperature (0-100 degrees C), salt (0-0.3 M), and pH (0-8). A global analysis over such a range of conditions permitted an unusually precise measure of the thermodynamic parameters, as well as the separation of the thermodynamics of the intrinsic unfolding reaction from the linked effects of protonation and chloride binding associated with acid-induced folding. The results indicate differences in the energetics of unfolding Sac7d and Sso7d that would not be apparent from an analysis of DSC data alone using conventional methods. The sign and magnitude of the changes in DeltaG, DeltaH, TDeltaS, and DeltaC(P) of unfolding resulting from core Ile/Val substitutions in the two proteins were consistent with differences in hydrophobicity of Val and Ile and negligible changes in packing (van der Waals) interactions. The benefit of increased hydrophobicity of the core increased with temperature, with maximal effect around 116 degrees C. Increased hydrophobicity of the core achieved not only an increase in the free energy of unfolding, but also a lateral shift of the temperature of maximal stability to higher temperature.
Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease

Shu-Ling Wang,Bo-Zong Shao,Sheng-Bing Zhao,Jun Fang,Lun Gu,Chao-Yu Miao,Zhao-Shen Li,Yu Bai

DOI: https://doi.org/10.3389/fimmu.2018.00693

IF: 7.3

2018-04-05

Frontiers in Immunology

Abstract:Intestinal mucosal barrier, mainly consisting of the mucus layer and epithelium, functions in absorbing nutrition as well as prevention of the invasion of pathogenic microorganisms. Paneth cell, an important component of mucosal barrier, plays a vital role in maintaining the intestinal homeostasis by producing antimicrobial materials and controlling the host-commensal balance. Current evidence shows that the dysfunction of intestinal mucosal barrier, especially Paneth cell, participates in the onset and progression of inflammatory bowel disease (IBD). Autophagy, a cellular stress response, involves various physiological processes, such as secretion of proteins, production of antimicrobial peptides, and degradation of aberrant organelles or proteins. In the recent years, the roles of autophagy in the pathogenesis of IBD have been increasingly studied. Here in this review, we mainly focus on describing the roles of Paneth cell autophagy in IBD as well as several popular autophagy-related genetic variants in Penath cell and the related therapeutic strategies against IBD.

immunology
Modulation of the Immunity and Inflammation by Autophagy

Ting Gan,Shu Qu,Hong Zhang,Xu-Jie Zhou

DOI: https://doi.org/10.1002/mco2.311

2023-01-01

MedComm

Abstract:Autophagy, a highly conserved cellular self-degradation pathway, has emerged with novel roles in the realms of immunity and inflammation. Genome-wide association studies have unveiled a correlation between genetic variations in autophagy-related genes and heightened susceptibility to autoimmune and inflammatory diseases. Subsequently, substantial progress has been made in unraveling the intricate involvement of autophagy in immunity and inflammation through functional studies. The autophagy pathway plays a crucial role in both innate and adaptive immunity, encompassing various key functions such as pathogen clearance, antigen processing and presentation, cytokine production, and lymphocyte differentiation and survival. Recent research has identified novel approaches in which the autophagy pathway and its associated proteins modulate the immune response, including noncanonical autophagy. This review provides an overview of the latest advancements in understanding the regulation of immunity and inflammation through autophagy. It summarizes the genetic associations between variants in autophagy-related genes and a range of autoimmune and inflammatory diseases, while also examining studies utilizing transgenic animal models to uncover the in vivo functions of autophagy. Furthermore, the review delves into the mechanisms by which autophagy dysregulation contributes to the development of three common autoimmune and inflammatory diseases and highlights the potential for autophagy-targeted therapies.
Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer

P Brest,E A Corcelle,A Cesaro,A Chargui,A Belaïd,D J Klionsky,V Vouret-Craviari,X Hebuterne,P Hofman,B Mograbi

DOI: https://doi.org/10.2174/156652410791608252

Abstract:Inflammatory bowel diseases (IBD) are common inflammatory disorders of the gastrointestinal tract that include ulcerative colitis (UC) and Crohn's disease (CD). The incidences of IBD are high in North America and Europe, affecting as many as one in 500 people. These diseases are associated with high morbidity and mortality. Colorectal cancer risk is also increased in IBD, correlating with inflammation severity and duration. IBD are now recognized as complex multigenetic disorders involving at least 32 different risk loci. In 2007, two different autophagy-related genes, ATG16L1 (autophagy-related gene 16-like 1) and IRGM (immunity-related GTPase M) were shown to be specifically involved in CD susceptibility by three independent genome-wide association studies. Soon afterwards, more than forty studies confirmed the involvement of ATG16L1 and IRGM variants in CD susceptibility and gave new information on the importance of macroautophagy (hereafter referred to as autophagy) in the control of infection, inflammation, immunity and cancer. In this review, we discuss how such findings have undoubtedly changed our understanding of CD pathogenesis. A unifying autophagy model then emerges that may help in understanding the development of CD from bacterial infection, to inflammation and finally cancer. The Pandora's box is now open, releasing a wave of hope for new therapeutic strategies in treating Crohn's disease.

Trade-off between the Use of Nonterminals, Codings and Homomorphisms in Defining Languages for Some Classes of Rewriting Systems

A Multiple Deep Trench Isolation Structure with Voltage Divider Biasing

The Role of Autophagy in Inflammatory Bowel Disease

Autophagy and proinflammatory cytokines: Interactions and clinical implications.

Roles of Autophagy-Related Genes in the Pathogenesis of Inflammatory Bowel Disease

Inflammatory Bowel Disease: Dysfunction of Autophagy?

Deciphering the role of autophagy in the immunopathogenesis of inflammatory bowel disease

The emerging roles of autophagy in intestinal epithelial cells and its links to inflammatory bowel disease

New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD

[Research updates: the mechanism of autophagy in inflammatory bowel disease]

How autophagy, a potential therapeutic target, regulates intestinal inflammation

Autophagy and Apoptosis in Inflammatory Bowel Disease

Interplay of autophagy and innate immunity in Crohn's disease: a key immunobiologic feature

Autophagy in Crohn's Disease: Converging on Dysfunctional Innate Immunity

Regulation of interferon signaling in response to gut microbes by autophagy

Targeting macrophage autophagy for inflammation resolution and tissue repair in inflammatory bowel disease

Cutting World Hunger in Half

Thermodynamics of core hydrophobicity and packing in the hyperthermophile proteins Sac7d and Sso7d.

Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease

Modulation of the Immunity and Inflammation by Autophagy

Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer